Phenotype and genetic variant analysis of seven pedigrees affected with blepharophimosis syndrome.
10.3760/cma.j.cn511374-20200729-00563
- Author:
Zhouxian BAI
1
;
Lina LIU
;
Xiangdong KONG
Author Information
1. Genetic and Prenatal Diagnosis Center, the First Affiliated Hospital of Zhengzhou University, Henan 450052, China. kongxd@263.net.
- Publication Type:Journal Article
- MeSH:
Blepharophimosis/genetics*;
Forkhead Box Protein L2/genetics*;
Forkhead Transcription Factors/genetics*;
Humans;
Mutation;
Pedigree;
Phenotype;
Skin Abnormalities;
Urogenital Abnormalities
- From:
Chinese Journal of Medical Genetics
2021;38(11):1060-1063
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the clinical manifestations and gene variants of patients with blepharophimosis, ptosis and epicanthus inversus syndrome (BPES).
METHODS:Clinical data of 7 pedigrees affected with BPES were collected, and genomic DNA was extracted from peripheral blood samples of the probands and their relatives. All exons of the FOXL2 gene were subjected to Sanger sequencing. Those with negative findings were further screened by targeted capture and next generation sequencing (NGS) and microarray analysis. Pathogenicity of candidate variants were predicted by search of PubMed and related databases, and the impact of the variants was interpreted by protein prediction software. Diagnosis was confirmed by clinical phenotype, medical history and mutation analysis.
RESULTS:A pathogenic variant was identified in six of the 7 pedigrees, which included four known pathogenic variants and one novel FOXL2 c.299dupA variant. A heterozygous 3q22.3q23 deletion, which encompassed the FOXL2 gene, was identified in another pedigree.As predicted, the c.299dupA frameshift mutation of FOXL2 gene can lead to the premature termination of protein translation, which is pathogenic.
CONCLUSION:A novel and 5 known pathogenic variants have been identified in six pedigrees affected with BPES by the combined Sanger sequencing, target capture NGS and microarray analysis. Above findings have enabled genetic counseling and prenatal diagnosis for these pedigrees.
